(R)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 95%, 1g

(S)-4-Benzyl-2-((benzyloxy)methyl)-1,4-oxazepane, 98%, 100mg

Silver Sulfate, 98.0%, 5g

3-(PYRIDIN-4-YL)PIPERAZIN-2-ONE, 95.0%, 250mg

(2R,5R)-1-(2-[(2R,5R)-2,5-Diethyl-1-phospholanyl]phenyl)-2,5-diethylphospholane 1-oxide, 97%, 5g

Methyl 5-fluoro-2-methylisonicotinate, 100mg

2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]-piperazin-1-yl]ethanol, 98.0%, 5g

2-(dimethylamino)-1,3,8-triazaspiro[4.5]dec-1-en-4-one dihydrochloride hydrate, 95.0%, 5g

Arachidonic acid, >99%, 50g

4,4,4-Trifluoro-1-(2-furyl)-1,3-butanedione, 99.0%, 1g

2-(3-Bromophenyl)-2-methylpropanoic acid, 95.0%, 10g

Boc-Val-Cit-PAB-PNP, 100mg

Colonna capillare per GC ROTI®Cap-1701, 60 m, 0,32 mm, 0,25 µm, 1 Pezzo(i)